Primecap Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-585,400
| Closed | -$8.46M | – | 327 |
|
|
2026
Q1 | $8.46M | Sell |
585,400
-4,000
| -0.7% | -$57.3K | 0.01% | 267 |
|
|
2025
Q4 | $8.39M | Sell |
589,400
-78,500
| -12% | -$771K | 0.01% | 262 |
|
|
2025
Q3 | $5.26M | Sell |
667,900
-128,200
| -16% | -$912K | ﹤0.01% | 282 |
|
|
2025
Q2 | $4.56M | Sell |
796,100
-123,400
| -13% | -$796K | ﹤0.01% | 287 |
|
|
2025
Q1 | $7.5M | Sell |
919,500
-15,300
| -2% | -$142K | 0.01% | 266 |
|
|
2024
Q4 | $8.81M | Sell |
934,800
-94,000
| -9% | -$977K | 0.01% | 258 |
|
|
2024
Q3 | $11M | Sell |
1,028,800
-23,700
| -2% | -$258K | 0.01% | 258 |
|
|
2024
Q2 | $10.4M | Sell |
1,052,500
-41,700
| -4% | -$428K | 0.01% | 256 |
|
|
2024
Q1 | $12.9M | Hold |
1,094,200
| – | – | 0.01% | 251 |
|
|
2023
Q4 | $15.5M | Hold |
1,094,200
| – | – | 0.01% | 240 |
|
|
2023
Q3 | $13.3M | Hold |
1,094,200
| – | – | 0.01% | 246 |
|
|
2023
Q2 | $13.7M | Sell |
1,094,200
-59,200
| -5% | -$702K | 0.01% | 246 |
|
|
2023
Q1 | $12.8M | Hold |
1,153,400
| – | – | 0.01% | 244 |
|
|
2022
Q4 | $14.1M | Sell |
1,153,400
-174,800
| -13% | -$1.97M | 0.01% | 235 |
|
|
2022
Q3 | $13.9M | Hold |
1,328,200
| – | – | 0.01% | 229 |
|
|
2022
Q2 | $14.3M | Sell |
1,328,200
-100,400
| -7% | -$827K | 0.01% | 234 |
|
|
2022
Q1 | $13.5M | Sell |
1,428,600
-99,400
| -7% | -$932K | 0.01% | 250 |
|
|
2021
Q4 | $17.6M | Sell |
1,528,000
-98,100
| -6% | -$1.09M | 0.01% | 247 |
|
|
2021
Q3 | $15.5M | Sell |
1,626,100
-218,900
| -12% | -$2.24M | 0.01% | 252 |
|
|
2021
Q2 | $17.8M | Sell |
1,845,000
-285,000
| -13% | -$2.78M | 0.01% | 242 |
|
|
2021
Q1 | $21M | Hold |
2,130,000
| – | – | 0.01% | 236 |
|
|
2020
Q4 | $49.2M | Hold |
2,130,000
| – | – | 0.04% | 190 |
|
|
2020
Q3 | $30.1M | Hold |
2,130,000
| – | – | 0.02% | 194 |
|
|
2020
Q2 | $32.1M | Sell |
2,130,000
-131,000
| -6% | -$1.6M | 0.03% | 183 |
|
|
2020
Q1 | $20.9M | Sell |
2,261,000
-34,000
| -1% | -$323K | 0.02% | 189 |
|
|
2019
Q4 | $22.4M | Buy |
2,295,000
+97,500
| +4% | +$893K | 0.02% | 208 |
|
|
2019
Q3 | $17.6M | Buy |
+2,197,500
| New | +$23.9M | 0.01% | 208 |
|
Other funds holding FOLD
Primecap Management's FOLD Position: Q2 2026 in Review
Primecap Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 585,400 shares — an estimated $8.46M sold.
Primecap Management first reported a position in FOLD in Q3 2019 and held it in 27 quarters. The position peaked at $49.2M in Q4 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Primecap Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Primecap Management sold 585,400 Amicus Therapeutics shares in Q2 2026, an estimated $8.46M.
- Primecap Management first reported a position in Amicus Therapeutics in Q3 2019 and held it in 27 quarters.
- Primecap Management's Amicus Therapeutics position peaked at $49.2M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Primecap Management's 13F filing for Q2 2026, filed 14 Aug 2026.